1928 Diagnostics - Chalmers Ventures

1928 Diagnostics

Antibiotic resistant bacteria is an emerging and serious threat to human health since some bacterial infections can no longer be treated with antibiotics. 1928 Diagnostics contributes to save the power of antibiotics by providing the 1928D platform, a cloud service that enables hospitals and authorities worldwide to use and interpret DNA data from bacteria for antibiotic treatment decision support and outbreak monitoring.

The 1928D platform will allow users to share data and thus strengthen global collaboration in tracking bacteria, increased infection control and more efficient use of antibiotics. The 1928D DNA data crunching platform will save lives, costs for hospitals and society and pave the path for more sustainable use of antibiotics.